InsiderTrades.com logo

BCRX Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,760,101.16

BioCryst Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at BioCryst Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCryst Pharmaceuticals Share Price & Price History

Current Price: $7.83
Price Change: ▼ Price Decrease of -0.02 (-0.25%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for BCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioCryst Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/3/2025Alane P. BarnesInsiderSell19,770$7.65$151,240.50345,476View SEC Filing Icon  
12/2/2025Alane P. BarnesInsiderSell50,906$7.21$367,032.26365,246View SEC Filing Icon  
12/1/2025Alane P. BarnesInsiderSell91,004$7.10$646,128.40416,152View SEC Filing Icon  
8/13/2025Theresa HeggieDirectorSell70,000$8.51$595,700.0065,352View SEC Filing Icon  
6/24/2024Amy E. McKeeDirectorSell8,600$6.32$54,352.0027,831View SEC Filing Icon  
6/17/2024Machelle SandersDirectorSell4,689$6.00$28,134.0027,742View SEC Filing Icon  
5/30/2024Alan G LevinDirectorBuy7,861$6.36$49,995.9644,951View SEC Filing Icon  
5/24/2024Steve AselageDirectorBuy2,500$6.40$16,000.002,500View SEC Filing Icon  
5/20/2024Nancy J. HutsonDirectorBuy5,000$6.38$31,900.0086,818View SEC Filing Icon  
5/14/2024Anthony DoyleCFOBuy36,300$5.57$202,191.00266,744View SEC Filing Icon  
5/14/2024Helen M. ThackrayInsiderBuy30,000$5.86$175,800.00272,139View SEC Filing Icon  
5/13/2024Steven K. GalsonDirectorBuy21,940$5.49$120,450.6051,551View SEC Filing Icon  
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.0025,611View SEC Filing Icon  
2/1/2023Jon P. StonehouseCEOSell100,000$10.38$1,038,000.001,008,739View SEC Filing Icon  
12/15/2022Anthony DoyleCFOSell5,700$10.90$62,130.00163,966View SEC Filing Icon  
12/15/2022Helen M. ThackrayInsiderSell3,125$10.89$34,031.25133,275View SEC Filing Icon  
12/15/2022Jon P. StonehouseCEOSell14,100$10.90$153,690.00887,730View SEC Filing Icon  
12/15/2022Michael L JonesDirectorSell445$10.90$4,850.5010,753View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCryst Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2025CIBC Bancorp USA Inc.22,330$0.17M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/18/2025Advisory Services Network LLC7,500$57K0.0%-79.3%0.004%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.370,463$2.81M0.0%-2.9%0.176%Search for SEC Filing on Google Icon
11/17/2025Caxton Associates LLP15,712$0.12M0.0%-44.6%0.007%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP107,530$0.82M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC957,021$7.26M0.0%-61.3%0.455%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC57,451$0.44M0.0%+162.4%0.027%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC16,524$0.13M0.1%+30.5%0.008%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC18,325$0.14M0.0%-18.7%0.009%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd2,410,362$18.30M0.0%+1.6%1.145%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC1,012,664$7.69M0.8%+0.5%0.481%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV10,613$81K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC460,947$3.50M0.0%-77.0%0.219%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.116,201$0.88M0.0%-10.3%0.055%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC343,771$2.61M0.0%+70.3%0.163%Search for SEC Filing on Google Icon
11/17/2025Farallon Capital Management LLC24,000$0.18M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth10,117$77K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Elevation Point Wealth Partners LLC10,728$81K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP325,795$2.47M0.0%+135.6%0.155%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.106,307$0.81M0.0%+49.1%0.050%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE1,902,819$14.44M0.0%-33.0%0.904%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC50,000$0.38M0.0%-81.8%0.024%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC63,242$0.48M0.0%-69.6%0.030%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC713,088$5.41M0.1%-28.9%0.339%Search for SEC Filing on Google Icon
11/17/2025Alkeon Capital Management LLC5,464,021$41.47M0.1%-4.4%2.595%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.278,333$2.11M0.0%+1.1%0.132%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC166,841$1.27M0.0%-77.8%0.079%Search for SEC Filing on Google Icon
11/14/2025Creative Planning88,477$0.67M0.0%+2.6%0.042%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC53,308$0.41M0.0%+91.4%0.025%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.105,102$0.80M0.0%+18.8%0.050%Search for SEC Filing on Google Icon
11/14/2025Deerfield Management Company L.P.12,169,000$92.36M1.4%+159.4%5.780%Search for SEC Filing on Google Icon
11/14/2025Man Group plc354,484$2.69M0.0%-16.0%0.168%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC901,500$6.84M0.2%N/A0.428%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC394,740$3M0.0%-43.0%0.187%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP4,419,629$33.55M0.0%+3.1%2.099%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC1,108,660$8.42M0.0%+53.3%0.527%Search for SEC Filing on Google Icon
11/14/2025Avoro Capital Advisors LLC1,250,000$9.49M0.1%-72.2%0.594%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC924,776$7.02M0.1%-31.4%0.439%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP731,411$5.55M0.0%+410.4%0.347%Search for SEC Filing on Google Icon
11/13/2025Entropy Technologies LP67,517$0.51M0.0%+228.8%0.032%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.962,376$7.30M0.0%-3.1%0.457%Search for SEC Filing on Google Icon
11/13/2025Arrowstreet Capital Limited Partnership5,225,986$39.67M0.0%+22.1%2.482%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.362,216$2.75M0.0%+62.3%0.172%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets2,094,278$15.90M0.0%+43.8%0.995%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp129,317$0.98M0.0%+21.4%0.061%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.465,338$3.53M0.0%+18.1%0.221%Search for SEC Filing on Google Icon
11/13/2025Magnetar Financial LLC116,020$0.88M0.0%+7.5%0.055%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc226,165$1.72M0.0%-81.2%0.107%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank385,368$2.93M0.0%+1.6%0.183%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.314,493$2.39M0.0%-28.6%0.149%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group535,968$4.05M0.0%N/A0.255%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.262,465$1.99M0.0%+57.6%0.125%Search for SEC Filing on Google Icon
11/13/2025First Trust Advisors LP734,987$5.58M0.0%+1.0%0.349%Search for SEC Filing on Google Icon
11/13/2025Knott David M Jr32,570$0.25M0.1%-90.2%0.015%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC782,232$5.94M0.0%-2.7%0.372%Search for SEC Filing on Google Icon
11/12/2025GW&K Investment Management LLC2,197,765$16.68M0.1%-16.2%1.044%Search for SEC Filing on Google Icon
11/12/2025Segall Bryant & Hamill LLC1,134,813$8.61M0.1%-7.0%0.539%Search for SEC Filing on Google Icon
11/12/2025Elo Mutual Pension Insurance Co127,504$0.97M0.0%+61.3%0.061%Search for SEC Filing on Google Icon
11/12/2025Fisher Asset Management LLC2,632,696$19.98M0.0%-5.4%1.250%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC369,322$2.80M0.0%+22.7%0.175%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP14,844$0.11M0.0%-58.9%0.007%Search for SEC Filing on Google Icon
11/12/2025R Squared Ltd21,672$0.16M0.1%N/A0.010%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC101,236$0.77M0.0%-18.5%0.048%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.38,697$0.29M0.0%+118.3%0.018%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP58,423$0.44M0.2%+338.7%0.028%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.17,500$0.13M0.0%-16.4%0.008%Search for SEC Filing on Google Icon
11/10/2025Vestmark Advisory Solutions Inc.10,728$81K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/10/2025Semanteon Capital Management LP43,544$0.33M0.4%N/A0.021%Search for SEC Filing on Google Icon
11/10/2025Hillsdale Investment Management Inc.561,600$4.26M0.1%+4.8%0.267%Search for SEC Filing on Google Icon
11/10/2025Empirical Financial Services LLC d.b.a. Empirical Wealth Management24,436$0.19M0.0%N/A0.012%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.36,796$0.28M0.0%-12.4%0.017%Search for SEC Filing on Google Icon
11/10/2025Jupiter Asset Management Ltd.2,055,915$15.60M0.1%-1.1%0.976%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP190,294$1.44M0.1%+70.7%0.091%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.21,790,881$165.39M0.0%+6.1%10.381%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.1,132,377$8.60M0.0%-28.5%0.539%Search for SEC Filing on Google Icon
11/7/2025Shell Asset Management Co.6,737$51K0.0%-54.6%0.003%Search for SEC Filing on Google Icon
11/6/2025Public Sector Pension Investment Board264,800$2.01M0.0%N/A0.126%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers326,835$2.48M0.0%-3.0%0.156%Search for SEC Filing on Google Icon
11/6/2025MQS Management LLC12,982$99K0.1%N/A0.006%Search for SEC Filing on Google Icon
11/6/2025Navellier & Associates Inc.66,870$0.51M0.1%+193.0%0.032%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC80,019$0.61M0.0%+25.6%0.038%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC43,297$0.33M0.0%-14.7%0.021%Search for SEC Filing on Google Icon
11/5/2025Alps Advisors Inc.101,125$0.77M0.0%-10.4%0.048%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC28,792$0.22M0.0%-42.4%0.014%Search for SEC Filing on Google Icon
11/5/2025Envestnet Asset Management Inc.29,713$0.23M0.0%+185.7%0.014%Search for SEC Filing on Google Icon
11/4/2025State of Wyoming37,083$0.28M0.0%+39.1%0.018%Search for SEC Filing on Google Icon
11/4/2025Principal Financial Group Inc.244,409$1.86M0.0%+29.9%0.116%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC64,103$0.49M0.0%-24.9%0.031%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.265,505$2.02M0.0%-11.0%0.126%Search for SEC Filing on Google Icon
10/31/2025Y Intercept Hong Kong Ltd434,531$3.30M0.1%+29.3%0.207%Search for SEC Filing on Google Icon
10/30/2025Universal Beteiligungs und Servicegesellschaft mbH41,169$0.31M0.0%+128.8%0.020%Search for SEC Filing on Google Icon
10/29/2025QTR Family Wealth LLC157,137$1.19M0.6%+3.4%0.075%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC21,824$0.15M0.0%-42.2%0.010%Search for SEC Filing on Google Icon
10/28/2025Csenge Advisory Group25,000$0.19M0.0%N/A0.012%Search for SEC Filing on Google Icon
10/28/2025Campbell & CO Investment Adviser LLC109,554$0.83M0.1%-73.4%0.052%Search for SEC Filing on Google Icon
10/24/2025Bayforest Capital Ltd70,031$0.53M0.3%-25.3%0.033%Search for SEC Filing on Google Icon
10/24/2025State of Alaska Department of Revenue11,899$90K0.0%N/A0.006%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC228,895$1.74M0.0%-2.8%0.109%Search for SEC Filing on Google Icon
10/22/2025Hennion & Walsh Asset Management Inc.85,745$0.65M0.0%+69.9%0.041%Search for SEC Filing on Google Icon
10/20/2025VIRGINIA RETIREMENT SYSTEMS ET Al113,004$0.86M0.0%+35.0%0.054%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More on BioCryst Pharmaceuticals

Today's Range

Now: $7.83
Low: $7.79
High: $8.17

50 Day Range

MA: $7.13
Low: $6.42
High: $7.85

52 Week Range

Now: $7.83
Low: $6.00
High: $11.31

Volume

6,714,520 shs

Average Volume

3,817,799 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top insider shareholders include:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Theresa Heggie (Director)
  6. Steven K Galson (Director)
  7. Alan G Levin (Director)
  8. Amy E Mckee (Director)
  9. Machelle Sanders (Director)
  10. Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.

Who are the major institutional investors of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 10.38%
  2. Deerfield Management Company L.P. — 5.78%
  3. Alkeon Capital Management LLC — 2.60%
  4. Arrowstreet Capital Limited Partnership — 2.48%
  5. Two Sigma Investments LP — 2.10%
  6. Assenagon Asset Management S.A. — 1.47%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.

Which major investors are selling BioCryst Pharmaceuticals stock?

During the last quarter, BCRX stock was sold by these institutional investors:
  1. Avoro Capital Advisors LLC
  2. Millennium Management LLC
  3. Voloridge Investment Management LLC
  4. Legal & General Group Plc
  5. Bank of America Corp DE
  6. Schonfeld Strategic Advisors LLC
  7. Assenagon Asset Management S.A.
  8. JPMorgan Chase & Co.
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.

Which major investors are buying BioCryst Pharmaceuticals stock?

Within the previous quarter, BCRX stock was bought by institutional investors including:
  1. Deerfield Management Company L.P.
  2. Vanguard Group Inc.
  3. Arrowstreet Capital Limited Partnership
  4. Orbimed Advisors LLC
  5. BNP Paribas Financial Markets
  6. Marshall Wace LLP
  7. Schroder Investment Management Group
  8. Squarepoint Ops LLC
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
  1. Alane P Barnes (Insider)
  2. Helen M Thackray (Insider)
  3. Anthony Doyle (CFO)
  4. Nancy J Hutson (Director)
  5. Theresa Heggie (Director)
  6. Steven K Galson (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.